<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate urinary 8-hydroxydeoxyguanosine (8-OHdG) as a marker for the progression of diabetic macroangiopathic complications </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: The content of urinary 8-OHdG, common carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>), the <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) risk score, the severity of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, and urinary albumin excretion were examined in 96 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, including 32 patients who had been nominated for the Kumamoto Study [Shichiri M, et al </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> Care 23 (Suppl 2):B21-B29, 2000] </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, the patients from the Kumamoto Study were further evaluated regarding the effect of intensive insulin therapy on urinary 8-OHdG excretion </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The urinary 8-OHdG:<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (U8-OHdG) was 2.5-fold higher in patients with increased HbA(1c) than in those with <z:mpath ids='MPATH_458'>normal</z:mpath> HbA(1c) (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, U8-OHdG was 2.3-fold higher in patients with increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> (P &lt; 0.005) </plain></SENT>
<SENT sid="6" pm="."><plain>A similar result was observed between U8-OHdG and CHD risk score (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>U8-OHdG was significantly higher in patients with simple <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (P &lt; 0.05) and those with advanced <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (P &lt; 0.01) than in patients without <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Similarly, U8-OHdG was significantly higher in patients with <z:mp ids='MP_0002871'>albuminuria</z:mp> (P &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, in the Kumamoto Study, U8-OHdG was significantly lower in the multiple insulin injection therapy group compared with the conventional insulin injection therapy group (P &lt; 0.01) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> independently increases 8-OHdG in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>8-OHdG is a useful biomarker of not only microvascular but also macrovascular complications in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>